Antibodies News and Research

RSS
Emerging SARS-CoV-2 variants contain mutations that interfere with genomic sequencing

Emerging SARS-CoV-2 variants contain mutations that interfere with genomic sequencing

The Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

The Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

Role of traditional medicine against SARS CoV-2

Role of traditional medicine against SARS CoV-2

Humoral innate pattern recognition molecules against SARS-CoV-2

Humoral innate pattern recognition molecules against SARS-CoV-2

Study reveals maternal and neonatal benefits of Pfizer COVID-19 mRNA vaccine

Study reveals maternal and neonatal benefits of Pfizer COVID-19 mRNA vaccine

Study shows poor antibody response in naive elderly of nursing homes after mRNA vaccination

Study shows poor antibody response in naive elderly of nursing homes after mRNA vaccination

AI identifies gene signatures to reveal patients’ immune responses to viral infection

AI identifies gene signatures to reveal patients’ immune responses to viral infection

High single-dose efficacy of Pfizer vaccine against SARS-CoV-2 in older adults

High single-dose efficacy of Pfizer vaccine against SARS-CoV-2 in older adults

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

SARS-CoV-2 infection detected in a poodle living with a COVID-19 positive family

SARS-CoV-2 infection detected in a poodle living with a COVID-19 positive family

Bio-inspired robot reveals motion pattern of ray sperms

Bio-inspired robot reveals motion pattern of ray sperms

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

In vivo protection from emerging SARS-CoV-2 variants by protein nanoparticle vaccine

In vivo protection from emerging SARS-CoV-2 variants by protein nanoparticle vaccine

Shark vNAR antibodies inhibit SARS-CoV-2 variants in vitro

Shark vNAR antibodies inhibit SARS-CoV-2 variants in vitro

Discovery suggests new pathways for safeguarding the immune system’s ability to fight cancer

Discovery suggests new pathways for safeguarding the immune system’s ability to fight cancer

ACTG launches phase 1 HIV cure study evaluating two promising therapies

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The longevity of SARS-CoV-2 antibodies and their cross-neutralization against variants of concern

The longevity of SARS-CoV-2 antibodies and their cross-neutralization against variants of concern

Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

Is B.1.617.2 more transmissible than earlier SARS-CoV-2 variants?

Is B.1.617.2 more transmissible than earlier SARS-CoV-2 variants?